MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
9.28
+0.22 (2.37%)
Nov 21, 2024, 1:32 PM EST - Market open
MiMedx Group Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for MiMedx Group stock have an average target of 12, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 29.38% from the current stock price of 9.28.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 1, 2024.
Analyst Ratings
The average analyst rating for MiMedx Group stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +18.60% | Aug 1, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +29.38% | Aug 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +18.60% | Jul 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.60% | May 1, 2024 |
| Lake Street | Lake Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +29.38% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
352.22M
from 321.48M
Increased by 9.56%
Revenue Next Year
384.58M
from 352.22M
Increased by 9.19%
EPS This Year
0.30
from 0.36
Decreased by -16.37%
EPS Next Year
0.32
from 0.30
Increased by 4.03%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 364.6M | 404.9M | 450.6M | ||
| Avg | 352.2M | 384.6M | 435.7M | ||
| Low | 336.1M | 365.9M | 416.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.4% | 15.0% | 17.2% | ||
| Avg | 9.6% | 9.2% | 13.3% | ||
| Low | 4.6% | 3.9% | 8.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.33 | 0.35 | 0.53 |
| Avg | 0.30 | 0.32 | 0.44 |
| Low | 0.27 | 0.28 | 0.36 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -10.4% | 14.0% | 66.0% |
| Avg | -16.4% | 4.0% | 40.3% |
| Low | -24.5% | -6.5% | 14.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.